FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
FDA General

Gottlieb Criticized on Industry Ties at Nomination Hearing

Faced with harsh criticism from Democrats about his ties to regulated industry, FDA commissioner nominee Scott Gottlieb tells members of the Senate He...

Human Drugs

Evidence Shortcuts Not Good for Breakthroughs: Professor

Yale School of Medicine cardiologist Harlan Krumholz says shortcuts to drug approvals such as using surrogate endpoints can increase patient risk and ...

Focus on Cybersecurity and IP Asset Protection: Foley

A Foley online guide lists six steps for life sciences and medical device companies to protect proprietary data and intellectual property assets from ...

Human Drugs

Silvergate Wants Epaned BE Requirements

Silvergate Pharmaceuticals asks FDA to impose specific bioequivalence requirements on any ANDA for a generic version of its antihypertensive Epaned.

Human Drugs

PhRMA Comments on FDA Enhanced Review Program

PhRMA says the FDA Program for Enhanced Review Transparency and Communications has increased the likelihood of first-cycle approval for some NDAs and ...

Human Drugs

Changes Needed to Counterfeit, Diversion Penalties: Attorney

Attorney Sheldon Bradshaw calls for stiffer penalties for drug counterfeiting and diversion.

Medical Devices

Murray Asks Olympus to Confirm Scope Safety

Sen. Patty Murray asks Olympus for data demonstrating that its repaired duodenoscopes can be reprocessed effectively.

Human Drugs

Judge Faults FDA, Still Rules Against Hi-Tech

A Georgia federal judge says Hi-Tech Pharmaceutical products containing DMAA are adulterated and subject to seizure because DMAA is not a dietary ingr...

Human Drugs

Philadelphia Court Rejects Off-label Claims

A Philadelphia Common Pleas Court judge throws out a suit alleging that Cephalon promoted a cancer opioid drug off-label that caused addiction in a pa...

Federal Register

Workshop on Kidney Transplant Rejection Drugs

Federal Register Notice: FDA announces a 4/12 public workshop on new developments and scientific issues related to antibody mediated rejection in kidn...